If you take Ramipril for blood pressure control, you may need to check your prescription.
The FDA has recalled 600,000 bottles of this widely used medication due to contamination concerns. The issue arises from an ingredient sourced from an unregulated manufacturer in India that did not meet proper supplier verification standards. While the FDA considers the health risk minimal, they have chosen to proceed with caution.
The recall applies to Ramipril capsules in 2.5 mg, 5 mg, and 10 mg strengths. This drug is commonly prescribed for hypertension, as it helps relax blood vessels and ease the heart’s workload, particularly after a heart attack.
Although no negative effects have been reported, it’s recommended to discard any affected bottles. The recalled products, manufactured by Lupin Pharmaceuticals, are sold in bottles of 90, 100, or 150 pills with expiration dates extending to July 2026.
